Insights & Resources

Discover how outsourcing in pharmaceutical manufacturing enhances quality, ensures compliance and mitigates risks in a rapidly evolving industry.

Learn how HMRC's guidelines impact transfer pricing for life sciences and other multinationals and how to mitigate risks and ensure compliance.

Texas’ direct pay permits can streamline tax compliance, improve cash flow and reduce costs for oil and gas companies.

In the oil and gas industry, an asset might be sold outright or as a disregarded entity, which is treated the same for federal income tax purposes.

J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.

KPMG has released their 2024 biopharma report detailing the challenges and opportunities for pharma companies moving forward into the new year.

Received a Schedule K-1 with upstream oil income? Learn the five key steps to ensure accurate reporting, including deductions for IDC, depletion and asset sales.

Learn about depletion deductions for oil & gas investors. Understand percentage and cost depletion, key tax benefits and the impact on taxable income.

IRS Notice 2024-52 confirmed the Marginal Well Credit applies in 2024, offering $0.77 per Mcf for qualified natural gas from marginal wells.

Shale maturation and technological innovation impact IP valuations, influencing long-term asset value and productivity in the oil and gas industry.

Discover how gas stations with c-stores qualify for bonus depreciation under the retail motor fuel outlet exception.

With an increasing demand for lithium across the energy sector, oilfields may find a common biproduct may hold the key to future growth.